Zhenwei Peng
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in
- Hepatology 78
- Hepatocellular Carcinoma Treatment and Prognosis 70
- Liver Disease and Transplantation 16
- Liver physiology and pathology 10
-
- Cancer, Lipids, and Metabolism 11
Zhenwei Peng
176 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Hepatology 2.8k
- Cancer Research 712
- Epidemiology 1.5k
- Oncology 933
- Pathology and Forensic Medicine 521
Countries citing papers authored by Zhenwei Peng
This map shows the geographic impact of Zhenwei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Peng more than expected).
Fields of papers citing papers by Zhenwei Peng
This network shows the impact of papers produced by Zhenwei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Peng. The network helps show where Zhenwei Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhenwei Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 46 | |
| 10 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Hit paper breakdown → | 2022 | 262 |
| 11 | 2021 | 98 | |
| 12 | 2021 | 25 | |
| 13 | 2018 | 18 | |
| 14 | 2017 | 13 | |
| 15 | 2017 | 29 | |
| 16 | 2017 | 219 | |
| 17 | Postseismic Slip Inferred from Repeating Earthquakes Following the 2012 Mw 7.6 Nicoya Earthquake in Costa Rica | 2014 | 1 |
| 18 | Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial Hit paper breakdown → | 2012 | 369 |
| 19 | Tremor evidence for dynamically triggered creep events on the deep San Andreas Fault | 2010 | 2 |
| 20 | Anomalous aftershock decay rates in the first hundred seconds revealed from the Hi-net borehole data | 2004 | 7 |
About Zhenwei Peng
Zhenwei Peng is a scholar working on Hepatology, Cancer Research, Energy Engineering and Power Technology, Pathology and Forensic Medicine and Epidemiology, having authored 190 papers that have together received 5.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (70 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (38 papers), Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (16 papers), Cancer Mechanisms and Therapy (13 papers), Cancer, Lipids, and Metabolism (11 papers), Liver physiology and pathology (10 papers) and Integrated Energy Systems Optimization (9 papers). The work is most often cited by research in Hepatology (2.8k citations), Cancer Research (712 citations), Epidemiology (1.5k citations), Oncology (933 citations) and Pathology and Forensic Medicine (521 citations). Zhenwei Peng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yaojun Zhang, Min-Shan Chen, Rong Guo, Hui-Hong Liang, Wan Yee Lau, Xiao-Jun Lin, Li Xu, Ya-Qi Zhang, Zishuo Huang and Shuling Chen. Their work appears in journals such as Journal of Clinical Oncology, Radiology, Frontiers in Oncology, International Journal of Hyperthermia and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.